NEW YORK (GenomeWeb News) — Roche e today said it has sold a 454 Life Sciences GS20 sequencer to the South African company Inqaba Biotechnical Industries. The deal includes the option to upgrade to a GS FLX.
Roche Diagnostics said it will provide Inqaba with support for the GS20’s applications.
Inqaba said it was supported by BioPAD, a South African government-funded trust and shareholder designed to create a sequencing service in the region.
The Pretoria-based Inqaba was established in 2002 with start-up funding from the US, Germany, and Switzerland.
Roche said Inqaba’s customer base includes several other African countries.
Financial terms of the deal were not released.